UBQLN4 promotes STING proteasomal degradation during cisplatin-induced DNA damage in triple-negative breast cancer

Clin Transl Med. 2022 Jul;12(7):e985. doi: 10.1002/ctm2.985.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cisplatin* / metabolism
  • Cisplatin* / pharmacology
  • DNA Damage / genetics
  • Humans
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Triple Negative Breast Neoplasms* / genetics
  • Triple Negative Breast Neoplasms* / metabolism

Substances

  • Carrier Proteins
  • Nuclear Proteins
  • UBQLN4 protein, human
  • Cisplatin